Warrington and Halton Hospitals CEO Professor Simon Constable and chairman Steve McGuirk officially open the new Clinical Research Unit at Halton Hospital A FUTURE coronavirus vaccine could be approved for use in the UK thanks to the contribution of Warrington residents. This is thanks to the opening of a new, dedicated facility for clinical research and trials at Halton Hospital. Halton Clinical Research Unit, within the Nightingale Building on the Runcorn site, will provide opportunities for people in Halton, Warrington, Cheshire and Merseyside to participate in clinical trials and research close to home. The unit has already received approval for its first clinical trial due to start next month, which is for a new Covid-19 vaccine candidate.
STAFF from the Western Health and Social Trust (Western Trust) joined volunteers from across Northern Ireland (NI) to take part in a milestone study into the new Novavax Covid-19 vaccine. Three members of the Western Trust Research Team – research nurses Dawn Small, Caitriona Lavery and Donal Concannon – all played an important role within the project. The study was a large UK-wide research initiative which aimed to assess the effectiveness of the Novavax vaccine against Covid-19, involving more than 15,000 participants. After successful trials, the interim study results reported on January 28 showed that the vaccine had an efficacy rate of 89.3 percent against the acquisition of Covid-19 and the development of severe Covid-19 infections.
Lifesaving: Dr Clive Graham, of the north Cumbrian NHS hospitals trust MORE than 500 covid patients who were treated at two north Cumbrian hospitals took part in a groundbreaking medical treatments trials, it has been revealed. The NHS trust which runs The Cumberland Infirmary in Carlisle and West Cumberland Hospital in Whitehaven has proved to be a top recruiter nationally for the scheme, known as the Randomised Evaluation of Covid-19 therapy (RECOVERY trial). Since its launch in March 2020, the trial - coordinated by Oxford University - has delivered compelling evidence on the efficacy of six treatments, including dexamethasone, a drug which was saves some of the most seriously ill Covid-19 patients.
Building research infrastructure across a health service cmaj.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cmaj.ca Daily Mail and Mail on Sunday newspapers.
Published: February 26th, 2021
The National Institute for Health Research (NIHR) Clinical Research Network (CRN) has appointed Samantha Liscio as its chief information and technology officer.Â
Having returned to the U.K. from Canada recently to assume her new role in April 2021, Lisco will be responsible for shaping and leading NIHR CRNâs information and digital services to ensure innovative data and systems are in place at the agency to enable efficient research delivery.Â
Liscio was the chief technology and innovation officer for the Workplace Safety and Insurance Board (WSIB), a government-funded agency providing no-fault liability insurance to more than five million workers in Ontario.